JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us
このページは機械翻訳されています。他のページは英語で表示される場合があります。 View in English

前立腺がん

  • 0Department of Radiotherapy-Oncology, Ghent University Hospital, Ghent, Belgium.
Lancet +

|

2025年12月19日

|

2025年12月19日

PubMedで要約を見る

まとめ

この要約は機械生成です。

前立腺がんの治療は 大きく進歩し 治療結果も改善されています 先進的な疾患には,標的薬を含む新しい全身療法があり,既定の治療法と怠惰な症例に対する積極的な監視も行われています.

科学分野

  • 腫瘍学
  • 泌尿器科

背景

  • 前立腺がんは 世界的に がんによる死亡の主な原因です
  • 最近の進歩により 前立腺がんの治療戦略は変わりました
  • 現在の治療法を理解することは 患者の管理に不可欠です

研究 の 目的

  • 前立腺がんの病理学,診断,治療について
  • 進化する治療の風景を強調するために
  • 前立腺がん患者の臨床的意思決定に情報を提供するため

主な方法

  • 前立腺がんの病理学,診断,治療に関する文献レビュー.
  • 現在の治療法と新たな治療法の分析
  • 病気の段階と患者の要因に基づく治療選択の検討

主要な成果

  • 前立腺がんの治療には,積極的な監視が推奨されます.
  • 局所的な治療は局所的な病気に有効です.
  • アンドロゲン欠乏療法,化学療法,Lu-177-PSMA放射性結合体療法,PARP阻害剤などの新薬を含む全身治療は,進行した転移性前立腺がんに不可欠です.

結論

  • 毒性や患者の好みを考慮した 共同意思決定が不可欠です
  • 転移性前立腺がんの治療順序と組み合わせを最適化するためにさらなる研究が必要です.
  • 前立腺がんの治療法は 進化を続け 患者の治療結果を改善しています

関連する概念動画

Disorders of the Male Reproductive System 01:20

3.9K

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....

Cancer Vaccines 01:30

929

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Cancer Survival Analysis 01:21

629

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

mTOR Signaling and Cancer Progression 03:03

4.6K

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Rous Sarcoma Virus (RSV) and Cancer 01:03

6.1K

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...